GlassScriptPhysician profile
Christine M Oehler
NPI 1275523136
$559.87
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $336 · 2020: $74.83 · 2021: $135 · 2022: $14.28.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $266.06 | 2019-2021 | |
| Duchesnay USA Incorporated | $57.76 | 2019 | |
| Lupin INC. | $49.13 | 2019-2020 | |
| Avion Pharmaceuticals | $28.17 | 2020-2021 | |
| Therapeuticsmd, INC. | $25.92 | 2019-2020 | |
| Mayne Pharma Commercial LLC | $21.38 | 2021 | |
| Amag Pharmaceuticals, INC. | $16.49 | 2019 | |
| Daiichi Sankyo INC. | $16.20 | 2019 | |
| Allergan, INC. | $14.37 | 2019 | |
| Boston Scientific Corporation | $14.28 | 2022 | |
| Hologic Sales and Service, LLC | $13.05 | 2019 | |
| Pfizer INC. | $12.49 | 2020 | |
| Merck Sharp & Dohme LLC | $12.49 | 2019 | |
| Vertical Pharmaceuticals, LLC | $12.08 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christine Oehler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.